Elastography and Treatment of Lymphoma

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05967975
Collaborator
(none)
44
28

Study Details

Study Description

Brief Summary

To determine accuracy of elastography in assessment of superficial lymph nodes response to treatment in cases of lymphoma.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Lymphomas are a heterogeneous group of malignancies that arise from the clonal proliferation of lymphocytes. It represents approximately 5% of malignancies. Overall survival is estimated to be 72%. (1)

    Lymphomas are broadly classified into Hodgkin lymphoma (HL) (10%) and Non-Hodgkin lymphoma (NHL) (90%).

    HL is further classified into classical and non-classical types and NHL into B-cell, T-cell and natural killer (NK) cell types. Diagnosis of lymphoma is confirmed by histopathology (FNAC, True-cut or excisional biopsy).(2) The standard treatment of lymphoma is chemotherapy and radiotherapy.

    The modalities used for staging and follow up of lymphoma are:
    • Computed Tomography (CT) chest, abdomen and pelvis.

    • Positron Emission Tomography (PET/CT).

    • Whole body Magnetic Resonance Imaging (MRI).(3)

    Sonoelastography is a new technique that depends on the elastic properties of soft tissues, with the idea of malignant lesions being stiffer than benign or normal tissue. It may have a dependable role in evaluation of therapeutic response in patients with lymphoma and can be used for follow up, the same way it has been used in different parts of the body, such as the breast, and thyroid. To the best of our knowledge, there are few studies concerning the role of elastography in the field of lymphoma disease.(4)

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    44 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Role of Sonoelastography in Evaluation of Therapeutic Response in Patients With Lymphoma.
    Anticipated Study Start Date :
    Aug 1, 2023
    Anticipated Primary Completion Date :
    Nov 1, 2025
    Anticipated Study Completion Date :
    Dec 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. To determine accuracy of elastography in assessment of superficial lymph nodes response to treatment in cases of lymphoma. [Average three years]

      Sonoelastography is a new technique that depends on the elastic properties of soft tissues, with the idea of malignant lesions being stiffer than benign or normal tissue. It may have a dependable role in evaluation of therapeutic response in patients with lymphoma and can be used for follow up, the same way it has been used in different parts of the body, such as the breast, and thyroid. To the best of our knowledge, there are few studies concerning the role of elastography in the field of lymphoma disease.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients who are histopathologically proven as lymphoma, not receive treatment and have superficial lymphadenopathy.
    Exclusion Criteria:
    • 1-Lymphoma without superficial lymph nodes. 2-patients under treatment.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Assiut University

    Investigators

    • Principal Investigator: Kerols Refaat, Resident, Assiut University
    • Study Director: Nagham Nabil, Professor, Assiut University
    • Study Director: Abdel-Monem Sayed, Lecture, Assiut University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kerols Refaat Ayoub, Resident doctor, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05967975
    Other Study ID Numbers:
    • Elastography and lymphoma
    First Posted:
    Aug 1, 2023
    Last Update Posted:
    Aug 1, 2023
    Last Verified:
    Jul 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 1, 2023